Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesCash from Financing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresLong-Term Debt RepaymentsNet Cash FlowNet IncomeShare-based Compensation
Growth Metrics
Income Statement
Others
Ratios

SeaStar Medical Holding (ICUCW) Net Income (2023 - 2025)

SeaStar Medical Holding's Net Income history spans 3 years, with the latest figure at -$2.9 million for Q4 2025.

  • For Q4 2025, Net Income rose 34.28% year-over-year to -$2.9 million; the TTM value through Dec 2025 reached -$12.1 million, up 51.07%, while the annual FY2025 figure was -$12.1 million, 51.07% up from the prior year.
  • Net Income reached -$2.9 million in Q4 2025 per ICUCW's latest filing, up from -$3.5 million in the prior quarter.
  • In the past five years, Net Income ranged from a high of -$2.0 million in Q2 2025 to a low of -$12.7 million in Q1 2024.
  • Average Net Income over 3 years is -$5.3 million, with a median of -$4.1 million recorded in 2024.
  • Peak YoY movement for Net Income: crashed 78.93% in 2024, then surged 70.29% in 2025.
  • A 3-year view of Net Income shows it stood at -$9.5 million in 2023, then soared by 53.27% to -$4.4 million in 2024, then skyrocketed by 34.28% to -$2.9 million in 2025.
  • Per Business Quant, the three most recent readings for ICUCW's Net Income are -$2.9 million (Q4 2025), -$3.5 million (Q3 2025), and -$2.0 million (Q2 2025).